The stock's rise snapped a four-day losing streak.

JPMorgan analyst Eric Joseph raised the firm’s price target on PTC Therapeutics (PTCT) to $78 from $72 and keeps an Overweight rating on the ...

In a report released today, Saket Kalia from Barclays maintained a Buy rating on PTC (PTC – Research Report), with a price target of $215.00.

We came across a bullish thesis on PTC Inc. (PTC) on Twitter by TMTMoats. In this article, we will summarize the bulls’ ...

Shares of PTC Inc. PTC shed 2.36% to $153.30 Thursday, on what proved to be an all-around poor trading session for the stock ...

BOSTON, March 13, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it has appointed Trac Pham to its Board of ...

PTC PTC has outperformed the market over the past 10 years by 6.09% on an annualized basis producing an average annual return of 16.42%. Currently, PTC has a market capitalization of $18.88 billion.

The DNA of tech® is a registered trademark of Vishay Intertechnology, Inc. MaxSiC™ is a trademark of MaxPower Semiconductor, ...

March 4 (Reuters) - Indian oil explorer Oil and Natural Gas Corp (ONGC.NS), opens new tab said on Tuesday its unit acquired clean energy firm PTC Energy for 9.25 billion Indian rupees ($106.02 ...

Joel Beatty; Analyst; Robert W. Baird & Co., Inc. Ladies and gentlemen, thank you for standing by. Welcome to the PTC Therapeutics fourth quarter and full year 2024 earnings conference call. (Operator ...

PTC Stock Down 0.2 % PTC stock opened at $162.75 on Friday. The stock has a market capitalization of $19.58 billion, a PE ratio of 50.23, a price-to-earnings-growth ratio of 2.27 and a beta of 1. ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...